Overview
Provides a comprehensive guide to the spectrum of emerging pharmacologic agents
Covers both standard of care and investigational therapeutics
Written by recognized international authorities in the field
Well suited for clinicians actively involved in the medical management of patients with prostate cancer
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (37 chapters)
-
Front Matter
-
Hormone Therapy
-
Front Matter
-
-
Cell Biology of Prostate Cancer and Molecular Targets
-
Hormone Therapy
-
Front Matter
-
Keywords
About this book
Reviews
From the reviews:
“For medical oncologists, trainees, researchers, and those in the pharmaceutical industry, Figg … offer a comprehensive and concise summary of the pharmacological treatments for prostate cancer, both current standard and investigative options. The 36 chapters … focus on a multidisciplinary care approach and cover hormone therapy, chemotherapy, angiogenesis, therapy for bones metastases, immunotherapy, chemoprevention, and drug development. Cell biology and molecular targets are also discussed.” (SciTech Book News, December, 2010)
“The 36 chapters in this book … read as independent discussions of many of the most recent discoveries in the area of drug management of prostate cancer. … suitable for medical students, physicians in training, physicians (especially medical oncologists), scientists, translational researchers, and members of the pharmaceutical industry. … An important aspect of this book is that the data represents updated, state-of-the-art information, making it valuable for daily reference. … an excellent resource for readers interested in the management of advanced prostate cancer … .” (Jianqing Lin, Doody’s Review Service, December, 2010)
“This treatise is an exhaustive description of the application of drug management of prostate cancer involving both standard care and investigational agents. … this book will give the reader a detailed insight about the current knowledge from clinical trials into the drug treatment of prostate tumours. The urologists, medical oncologist and others involved in the treatment of the prostate cancer will find in this work a complete review of where we are now.” (M. Horňák, Neoplasma, March, 2011)
“This textbook by W.D. Figg and co-authors … makes an exhaustive overview of present and future medical therapies of prostate cancer. … This book provides the reader with comprehensive information about pharmacological treatments of prostate cancer. All chapters are concise and most of them are well-illustrated. We recommend this textbook to urologists, oncologists who are involved in prostate cancer management, and to all physicians and students who want to update their knowledge in prostate cancer management.” (European Urology Today, April/May, 2011)
Editors and Affiliations
Bibliographic Information
Book Title: Drug Management of Prostate Cancer
Editors: William D. Figg, Cindy H. Chau, Eric J. Small
DOI: https://doi.org/10.1007/978-1-60327-829-4
Publisher: Springer New York, NY
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Science+Business Media, LLC 2010
Hardcover ISBN: 978-1-60327-831-7Published: 17 September 2010
Softcover ISBN: 978-1-4614-0184-1Due: 14 June 2031
eBook ISBN: 978-1-60327-829-4Published: 14 September 2010
Edition Number: 1
Number of Pages: XVIII, 430
Number of Illustrations: 12 b/w illustrations, 22 illustrations in colour
Topics: Oncology, Urology, Internal Medicine